Evidence of bacterial biofilms in nasal polyposis.

INTRODUCTION: The pathogeny of chronic rhinosinusitis with nasal polyposis (CRS/NP) has not been elucidated. Bacterial exotoxins have been implicated in many inflammatory chronic diseases, such as chronic otitis, chronic tonsillitis, cholesteatomas, and more recently CRS/NP. We propose that the bacteria in CRS/NP are not only present in a planktonic state, but also occur in microbial communities as biofilms. OBJECTIVE: To determine and characterize the presence of biofilms in CRS/NP. METHODS: We performed a prospective study in 12 patients undergoing endoscopic sinus surgery for nasal polyposis. Ten patients without CRS/NP who underwent septoplasty were included as a control group. Tissue samples were obtained from the inferior turbinate mucosae. The bacteria were isolated and typified and the material was examined in vitro using a spectrophotometer, and in vivo using optical microscopy and confocal scanning laser microscopy. RESULTS: Moderate to high in vitro biofilm-forming capacity was detected in 9 out of 12 patients with CRS/NP (mean [SD] optical density values of between 0.284 [0.017] and 3.337 [0.029]). The microorganisms isolated were Staphylococcus (5 patients), Streptococcus viridans, Pseudomonas aeruginosa, Enterococcus faecalis and Streptococcus viridans/Corynebacterium. Biofilms were demonstrated in vivo in 2 patients and no biofilm structures were evident in any of the controls. CONCLUSION: This study demonstrates the presence of bacterial biofilms in patients with CRS/NP. This chronic inflammatory factor might contribute to nasal mucosa damage, increased inflammatory cells in tissue, and the subsequent hyperplasic process.

Adolescent smokers are at greater risk for current asthma and rhinitis.

BACKGROUND: The association of tobacco smoke with the prevalence of asthma and rhinitis has not been well-characterized in adolescents. METHODS: As part of the International Study of Asthma and Allergies in Childhood (ISAAC), we conducted a cross-sectional survey of 3000 adolescents aged 13-14 years in northern Argentina. Data included questions about asthma and rhinitis symptoms and about parental and personal smoking. Logistic regression and Pearson chi(2) statistics were used to estimate these associations. RESULTS: Over 13% of respondents described themselves as current smokers, and half indicated that at least one parent smoked at home. Active smoking was associated with both asthma (OR 1.83, 95%CI 1.42-2.35) and rhinitis (OR 1.61, 95%CI 1.33-1.92) in unadjusted analysis. These associations persisted after adjusting for parental smoking status, mother's educational level and sex. Boys were significantly less likely than girls to report current asthma or rhinitis. CONCLUSIONS: Active and passive smoking are both risk factors for asthma and rhinitis in adolescents. Assuming that some children with asthma never started smoking due to symptoms, then the true risk could be higher than reported here. These results reinforce the need to develop better strategies for primary and secondary prevention of tobacco exposure in children.

Is secondary lymphoid-organ chemokine (SLC/CCL21) much more than a constitutive chemokine?

Chemokines are a superfamily of small cytokines with activities ranging from leukocyte traffick to hematopoiesis, angiogenesis, and tissue organogenesis. Secondary lymphoid-organ chemokine (SLC/CCL21) was originally reported as a chemokine constitutively expressed by stromal cells and high endothelial venules in secondary lymphoid tissues and endothelium of afferent lymphatics, directing CCR7+ cells. More recently, others and we have demonstrated that SLC/CCL21 is up-regulated in different skin inflammatory conditions. Thereafter, this molecule is much more than a constitutive chemokine, which could play a role in effector and regulatory immune functions.

Expression of CS-1 fibronectin precedes monocyte chemoattractant protein-1 production during elicitation of allergic contact dermatitis.

BACKGROUND: Leucocyte migration within inflammatory skin compartments in allergic contact dermatitis (ACD) is the result of a sophisticated multi-step event where multiple molecules are involved. OBJECTIVE: Since non-antigen-specific mechanisms have been described as an early participant in elicitation of ACD, we investigated the kinetics of the expression of monocyte chemoattractant protein-1 (MCP-1/CCL2) and the type of infiltrating cells. We compared the time course production of MCP-1/CCL2 with connecting segment-1 (CS-1) fibronectin and thymus and activation-regulated chemokine (TARC/ CCL17) expression. METHODS: Biopsies from 10 individuals challenged in their back with the antigen responsible for their contact dermatitis and an irrelevant antigen were taken at different times and histology, immunohistochemistry for CS-1 fibronectin, TARC/CCL17, CD3, CD68, CXCR3, CCR4 and in situ hybridization for MCP-1/CCL2 were performed. RESULTS: At positive antigen stimulated sites expression of MCP-1/CCL2 by basal keratinocytes and isolated cells in dermis started at 10 h. CS-1 fibronectin and TARC/CCL17 expression by blood endothelial cells was found at 2 and 10 h, respectively. This was followed by dermal accumulation of mononuclear cells with a significant increase of CD3+ and CD68+cells. At 48 h, approximately 58% of infiltrating cells were CXCR3+, and 35% CCR4+. CONCLUSIONS: We showed evidence of the fact that CS-1 fibronectin expression precedes the production of MCP-1/CCL2 and TARC/CCL17 in the skin of patients with ACD, suggesting that these molecules participate in the early complex process of migrating mononuclear cells during elicitation of ACD.

Clinical signs and symptoms are not enough for the correct diagnosis of allergic conjunctivitis.

BACKGROUND: Allergic Conjunctivitis (AC) has a high incidence in the general population and sometimes it is difficult to make a correct diagnosis, distinguish among the different subtypes of AC, and therefore, to indicate the suitable therapy. OBJECTIVE: To determine the best way to carry out an appropriate diagnosis of AC. METHODS: Thirty-one patients with clinical manifestations of AC and eleven controls were studied by measuring allergic and immunologic parameters. Only those patients confirmed as having AC were treated with ketotifen fumarate and further evaluated. RESULTS: According to allergic and immunological parameters, patients were divided into two groups. Group I patients had positive prick test toward at least one allergen, 60% exhibited high levels of tear-IgE, and only 36% conjunctival eosinophils. By contrast, patients from Group II had negative prick tests and laboratory findings similar to the control group. In group I there was a good correlation between levels of tear-IgE and eosinophils (r = 0.55; p = 0.009); key symptoms and signs and prick test (r = 0.52; p = 0.015), and prick test and eosinophils (r = 0.50 p = 0.022). The cardinal signs and symptoms scores dropped significantly in Group I as a consequence of the treatment (p < 0.0001). CONCLUSION: In order to have a reliable AC diagnosis, allergen-skin prick test, IgE in tears, and conjunctival eosinophils must be studied. Serum IgE is less important.

Desloratadine activity in concurrent seasonal allergic rhinitis and asthma.

Seasonal allergic rhinitis (SAR) and asthma, which are frequently comorbid, share some common allergic pathogenic bases. Clinical manifestations of these disorders might therefore be viewed as local manifestations of a systemic inflammatory state. Not only do the onsets of allergic-rhinitis (AR) and asthma symptoms often coincide (within 1 year), but also nasal challenges with SAR allergens can induce airways hyperreactivity (AHR). Eosinophils, which are key effector cells in both SAR and asthma, cause AHR, tissue damage, and neuronal effects through secretion of toxic granule proteins, enzymes, and other mediators. The novel, nonsedating, histamine H1-receptor antagonist, desloratadine, which exerts various favorable effects on the allergic cascade, significantly decreased SAR symptoms (e.g., nasal congestion) and diminished daily beta2-agonist use and improved asthma symptoms, while maintaining pulmonary function, in patients with SAR-asthma who were treated with once-daily desloratadine regimens.

Allergic rhinitis and asthma in children: disease management and outcomes.

Antihistamines and inhaled glucocorticoids, which can be targeted toward multiple points in the "allergic cascade" underlying allergic rhinitis and asthma, extend the promise of enhanced outcomes in children with allergic rhinitis, asthma, or both. Antihistamine therapy confers significant relief of subjective ratings of seasonal and perennial allergic symptoms (e.g., rhinorrhea, congestion, sneezing, pruritus), whereas topical steroids alleviate such discomfort while also improving objective anatomic and functional indices of nasal patency (e.g., nasal peak inspiratory flow). Youngsters with asthma also experience substantial clinical benefits from inhaled steroids, which improve objective measures of pulmonary function and reduce rescue beta 2-agonists for symptom management and quality-of-life enhancement. This paper reviews recent clinical findings on the role of antihistamines and topical corticosteroids in pediatric allergy and asthma management, as well as the favorable effects of these medications on both objective and subjective health outcomes.

Role of food allergy in asthma in childhood.

Atopy is the major predisposing factor for asthma identified up to now, and allergen exposure, particularly indoor allergens, is considered as a causal factor for asthma. Food allergy is frequently underestimated in association with asthma, however food allergy has been shown to trigger or exacerbate broncho-obstruction in 2 to 8.5% of children with asthma. There is also evidence that double-blind placebo-controlled oral challenge is able to increase unspecific bronchial hyperresponsiveness. Sensitization to food can occur early in life involving T cell response, mainly of the Th2 phenotype, but also IgE-mediated hypersensitivity. Moreover, it has been shown that sensitization to food allergens early in life is a risk factor for sensitization to inhalent allergens and respiratory symptoms later on. Epidemiological studies suggest that changes in the dietary composition, such as trans-fatty acids, could be involved in the increase of asthma prevalence. The introduction of formula during the first trimester of life increases the risk of having asthma. The diagnosis of food allergy associated with asthma is not easy, nevertheless is important for allergists, pulmonologists and paediatricians to consider food allergy in children with respiratory symptoms, especially when asthma symptoms start early in life and when they are associated with other manifestations of food allergy. Children sensitized to cow's milk proteins and also having atopic eczema are at higher risk for asthma. Since avoidance of the offending food is the first step in the management of children with asthma associated with food allergy, a careful identification should be done in order to avoid unnecessary elimination of foods.

[Dissemination program of GINA in Mexico]. / Programa de diseminación de GINA en México.

Asthma is a global public health problem. Even though the prevalence is variable in different parts of the world, including Latin America, asthma morbility is high, particularly in countries with emerging economies. Asthma mortality is unacceptable, especially since it has been estimated that a high percentage of asthma deaths could be prevented. Fortunately, most patients suffer mild persistent asthma, however, there is evidence that asthma is many times underdiagnosed and undertreated. Primary care physicians, family doctors and paediatricians have to deal with the majority of asthma patients together with different medical conditions; such as heart problems, diabetes, and infectious, etcetera. In order to help these physicians in the process of decision making, guidelines have been developed. There are many asthma guidelines; they range from opinion based guidelines (in the past) to a current more evidence based approach. Among GINA, Global Initiative for Asthma, is the most comprehensive and widespread all around the world. More than a guideline, GINA is actually a programme directed at asthma specialists, other health care providers and patients and their families.

Asthma mortality in Latin America.

There are not enough data concerning asthma mortality in Latin America. The Latin American Society of Allergy and Immunology coordinated this project to provide reliable data for gaining knowledge about our present situation, which is a condition indispensable to changing it. The following countries participated in this study: Argentina, Brazil, Chile, Colombia, Costa Rica, Cuba, Mexico, Paraguay, Peru, Uruguay and Venezuela. A uniform protocol was designed in Santa Fe, Argentina. Asthma mortality rates were analyzed in accordance with two variables: age-adjusted rates (5-34) and total death rates. The total population studied was 107, 122, 529 inhabitants. The highest death rates were found in Uruguay and Mexico (5.63), and the lowest in Paraguay (0.8) and Colombia (1.35). Age-adjusted (5-34) rates were higher in Costa Rica (1.38) and lower in Chile (0.28). Regarding sex, the analysis of the information provided by seven countries showed a predominance of females (51.8%) over males (48.18%). In the southern Latin American countries such as Chile, Uruguay, Paraguay and Argentina, which have marked climatic differences, deaths occurred mainly in the winter. It is important to emphasize that, in most countries, deaths from asthma occurred at home: Chile (60.7%), Argentina (63.4%) and Paraguay (88%). However, in Uruguay, 58.6% occurred during hospitalization. Mortality rates from bronchial asthma are high in most of the Latin American countries studied, even though further studies are needed. Asthma is a serious global health problem. People of all ages in countries throughout the world are affected by this chronic airway disorder that can be severe and sometimes fatal. The health ministries of each country do not believe asthma is a significant issue. Therefore, we should provide them with sound epidemiological studies to convince them to change their attitude toward this disease.

Sensibilidad cutánea a ácaros domésticos y de deposito en niños y adultos asmáticos / Cutaneous sensibility to domestic and of deposit acarus in asthmatics children aqnd adults

La alergia a los ácaros del polvillo doméstico en asociación al asma es, actualmente considerado un problema de diseminación mundial. Entre el 70 al 90% de los pacientes asmáticos tienen test cutáneo positivos a extractos de ácaros, particularmente a D. pteronyssinus y D. farinae. Numerosos estudios han encontrado sensibilidad cutánea a otros Piroglífidos, tal el caso de E. maynei. En los depósitos de granos, alimentos y maderas, entre otros, se han hallado ácaros que se desiganaron "de almacenamiento" y que ahora son llamados "domésticos" ya que también se pueden encontrar en las viviendas. No conocíamos la prevalencia de sensibilidad a extractos de otros ácaros del sub-orden astigmata. En este estudio se presentan la frecuencia de sensibilización cutánea en niños asmáticos de Córdoba y niños y adultos asmáticos de Santa Fe a extractos de D. pteronyssinus, D. farinae, B. tropicalis, A. ovatus, C. arcuatus y L. destructor. Tanto en los pacientes asmáticos de Córdoba como de Santa Fe, la mayor frecuencia de sensibilización cutánea fue a D. pteronyssinus, 63.3% y 72.7% respectivamente. B. tropicalis fue el segundo alergeno hallado en Córdoba (58.3%) y D. farinae en Santa Fe (66.6%). Los extractos alergénicos de los otros ácaros estudiados arrojaron positividades entre el 6 y el 57.5% de los casos estudiados. Los ácaros del sub-orden Astigmata, no Piroglífidos, son capaces de inducir sensibilidad cutánea en niños y adultos asmáticos de nuestro país

Sensibilidad cutánea a ácaros domésticos y de deposito en niños y adultos asmáticos / Cutaneous sensibility to domestic and of deposit acarus in asthmatics children aqnd adults

La alergia a los ácaros del polvillo doméstico en asociación al asma es, actualmente considerado un problema de diseminación mundial. Entre el 70 al 90% de los pacientes asmáticos tienen test cutáneo positivos a extractos de ácaros, particularmente a D. pteronyssinus y D. farinae. Numerosos estudios han encontrado sensibilidad cutánea a otros Piroglífidos, tal el caso de E. maynei. En los depósitos de granos, alimentos y maderas, entre otros, se han hallado ácaros que se desiganaron "de almacenamiento" y que ahora son llamados "domésticos" ya que también se pueden encontrar en las viviendas. No conocíamos la prevalencia de sensibilidad a extractos de otros ácaros del sub-orden astigmata. En este estudio se presentan la frecuencia de sensibilización cutánea en niños asmáticos de Córdoba y niños y adultos asmáticos de Santa Fe a extractos de D. pteronyssinus, D. farinae, B. tropicalis, A. ovatus, C. arcuatus y L. destructor. Tanto en los pacientes asmáticos de Córdoba como de Santa Fe, la mayor frecuencia de sensibilización cutánea fue a D. pteronyssinus, 63.3% y 72.7% respectivamente. B. tropicalis fue el segundo alergeno hallado en Córdoba (58.3%) y D. farinae en Santa Fe (66.6%). Los extractos alergénicos de los otros ácaros estudiados arrojaron positividades entre el 6 y el 57.5% de los casos estudiados. Los ácaros del sub-orden Astigmata, no Piroglífidos, son capaces de inducir sensibilidad cutánea en niños y adultos asmáticos de nuestro país

Pollinosis: some immunologic and regional considerations and the description of Melia azedarach respiratory allergy.

Pollens constitute one of the most allergenic groups for man. Their prevalence make them an important factor when studying antigens that induce allergical diseases such as rhinitis, asthma, conjunctivitis, etc., wherein immunological mechanisms play a fundamental role. It is believed that genetic factors are involved in pollinosis and this could probably explain the enhanced susceptibility of certain individuals to acquire this type of allergy. Here we mention the HLA system, among others involved. Ecological aspects of each region must be carefully evaluated because of the importance of detecting the specific pollen area and the pollen's behaviour which, in turn, will permit an accurate etiological diagnosis. We have investigated a pollen widely spread in our province, called Melia azedarach and have demonstrated its property of inducing allergic respiratory disease. Finally, therapeutics in pollinosis is discussed and attention is paid to drugs such as antihistamines, ketotifen, among others but we think that specific immunotherapy plays a most important role.